GSA Capital Partners LLP Raises Position in InfuSystem Holdings, Inc. (NYSE:INFU)

GSA Capital Partners LLP grew its position in InfuSystem Holdings, Inc. (NYSE:INFU) by 23.9% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 65,680 shares of the company’s stock after purchasing an additional 12,657 shares during the quarter. GSA Capital Partners LLP’s holdings in InfuSystem were worth $440,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of INFU. Kings Path Partners LLC purchased a new position in InfuSystem in the second quarter worth about $514,000. First Eagle Investment Management LLC lifted its position in InfuSystem by 10.0% during the second quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock valued at $4,549,000 after purchasing an additional 60,813 shares during the period. Sequoia Financial Advisors LLC bought a new position in InfuSystem during the second quarter valued at approximately $272,000. Squarepoint Ops LLC bought a new position in InfuSystem during the second quarter valued at approximately $230,000. Finally, Panagora Asset Management Inc. bought a new position in InfuSystem during the second quarter valued at approximately $208,000. 71.13% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on INFU shares. StockNews.com upgraded shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 8th. B. Riley started coverage on shares of InfuSystem in a research report on Thursday, September 26th. They set a “buy” rating and a $13.00 price objective on the stock.

InfuSystem Price Performance

Shares of NYSE INFU opened at $9.03 on Thursday. The stock has a fifty day moving average price of $7.03. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $191.87 million, a PE ratio of 150.44 and a beta of 1.45. InfuSystem Holdings, Inc. has a 1 year low of $5.74 and a 1 year high of $10.99.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.